PV Audit-as-a-Service

Strategic, End-to-end Audit Expertise for Confident, Inspection Ready Pharmacovigilance

Qinecsa is the partner of choice for PV Audit-as-a-Service, combining global regulatory expertise, physician-led audit teams, and technology-enabled delivery to provide unmatched visibility into compliance, risk, and inspection readiness. Our strategic, end-to-end approach goes beyond traditional audits—delivering actionable insights, strengthening governance, and enabling confident, data-driven decision-making across your pharmacovigilance operations.

What Is Pharmacovigilance Audit Services and Why It Matters

Pharmacovigilance audit services help organisations maintain compliance with EMA, FDA, MHRA, and ICH expectations by providing independent, expert assessment of all PV operations. These audits ensure the integrity of safety systems, the robustness of processes, and the readiness of teams ahead of regulatory inspections.

For senior leaders, the stakes are high. Inconsistent audit scheduling, fragmented documentation, or insufficient oversight can lead to compliance gaps, operational risk, or regulatory findings. Qinecsa’s PV Audit as a Service solves these challenges through:

• Independent, expert led review of governance, case processing, reporting workflows, and system compliance.
• Gap analysis against global and local regulations with clear, actionable remediation plans.
• A structured approach that ensures inspection ready pharmacovigilance systems and clarity for internal teams.
• Strategic insight that supports quality improvement, operational efficiency, and enhanced patient protection.

Pharmacovigilance audits are more than regulatory requirements — they are essential mechanisms for risk reduction, corporate governance, and maintaining global safety excellence.

How Pharmacovigilance Audit Services Fit into Your Wider PV Strategy

Pharmacovigilance Audit Services play a foundational role within the broader PV ecosystem by validating how effectively safety processes operate in practice.

By independently reviewing activities such as case processing, signal management, risk evaluation, and regulatory reporting, audits confirm compliance, reinforce data integrity, and support consistent execution across regions and partners. The result is a resilient, inspection‑ready pharmacovigilance system aligned with organizational strategy.

Why Qinecsa for Pharmacovigilance Audit Services

Qinecsa combines deep pharmacovigilance expertise with a strategic, technology‑enabled audit framework designed for complex, global organizations.

Expert Pharmacovigilance Auditors

Audits are conducted by physicians and senior PV professionals with hands‑on experience across EMA, FDA, MHRA, ICH, and national authority expectations. This ensures practical insight, regulatory credibility, and defensible outcomes.

Technology‑Enabled Delivery

Digital dashboards, structured reporting, and CAPA tracking provide real‑time visibility into audit findings and remediation progress. Technology enhances consistency, transparency, and leadership oversight across audit programs.

Global and Local Regulatory Insight

Qinecsa supports multi‑region and multi‑product portfolios, combining global standards with country‑specific regulatory understanding. This ensures audits are relevant, proportionate, and aligned with local expectations.

Integrated PV Ecosystem

Audit outputs align seamlessly with Qinecsa’s broader PV services, including case management, signal detection, regulatory support, and quality frameworks—creating a connected, end‑to‑end safety ecosystem.

Qinecsa’s Approach to Pharmacovigilance Audit Services

Qinecsa applies a structured, risk‑based methodology that delivers meaningful regulatory assurance and operational insight.

Comprehensive Planning

Audit programs are tailored to organizational maturity, product portfolio, regions, and risk profile to ensure relevance and efficiency.

Regulatory Excellence

Audits are mapped against current global and local guidance, ensuring alignment with evolving regulatory expectations.

Risk Based Execution

Resources focus on high‑impact and high‑risk areas, maximizing value while minimizing disruption to ongoing PV operations.

Actionable Reporting

Clear, executive‑level reporting highlights strengths, gaps, and priority CAPAs for leadership and operational teams.

Key Features of Our Pharmacovigilance Audit Services Solution

For the Organization

• Strong alignment with EMA, FDA, MHRA, and ICH requirements
• Reduced regulatory, operational, and portfolio risk
• End‑to‑end audit coverage across systems, processes, and governance
• Consistent global standards with scalable delivery models

For Internal Teams

• Clear expectations and strengthened compliance culture
• Improved collaboration across PV, regulatory, and clinical functions
• Greater confidence in inspection readiness
• Focused prioritization and workflow improvement

For Patients and Healthcare Professionals

• Stronger safety oversight across the product lifecycle
• Earlier identification of quality or safety issues
• Increased confidence in the organization’s commitment to patient safety

Benefits of Pharmacovigilance Audit Services With Qinecsa

For the Organization

• Confident regulatory compliance and inspection readiness
• Reduced exposure to findings, penalties, and reputational damage
• Data‑driven governance and improved operational decision‑making
• Consistent application of safety standards worldwide

For Internal Teams

• Objective, actionable insight to strengthen PV processes
• Independent validation of quality and compliance
• Improved alignment across global and local safety teams

For Patients and Healthcare Professionals

• Enhanced safety monitoring supported by robust quality systems
• Faster detection and escalation of potential safety concerns

FAQs - PV Audit-as-a-Service

What is PV Audit-as-a-Service?
It is a managed audit solution that evaluates pharmacovigilance processes, SOPs, and governance structures to ensure global regulatory compliance.

Why is PV Audit-as-a-Service important for senior leaders?
It provides assurance that PV operations are compliant, inspection-ready, and aligned with corporate risk management objectives.

Can Qinecsa perform audits for global operations?
Yes. Our service is scalable and designed to support multi-region, multi-product PV programmes.

How are audit findings reported?
We provide executive-focused reports and dashboards with actionable recommendations and CAPA tracking.

Are the audits inspection-ready?
All audits are designed to ensure documentation and processes can withstand regulatory scrutiny.

How does PV Audit-as-a-Service integrate with other PV functions?
Audits are aligned with case management, signal detection, regulatory responses, and quality frameworks for holistic compliance oversight.

Can you help implement corrective actions?
Yes. Qinecsa provides guidance and monitoring to ensure CAPAs are implemented effectively and sustainably.

What is the typical timeline for an audit?
Timelines depend on scope and complexity, but Qinecsa provides structured, efficient audits with clear milestones.

How often should audits be conducted?
Frequency is risk-based and tailored to the organisation’s portfolio, regulatory requirements, and operational needs.

Can PV Audit-as-a-Service improve inspection outcomes?
Yes. By identifying gaps, providing actionable recommendations, and monitoring CAPAs, audits enhance inspection readiness and regulatory confidence.

Talk to a PV Specialist

Qinecsa’s PV Audit as a Service empowers organisations with strategic, expert led pharmacovigilance audit services that reinforce global compliance and enhance patient safety. Whether preparing for an upcoming inspection or elevating your quality framework, our team provides the insight, structure, and assurance you need across your entire PV ecosystem.